Wednesday, 15 Aug 2018

You are here

The RheumNow Week in Review – Handshakes or Hugs (8.3.18)

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com, including new treatments for LTBI, gout consequences, RA and offspring risk, PsA risk, and the opioid epidemic effects.

  1. NEJM study of Latent TB in adults shows 4 mos Rifampin (10mg/kg/d) to be noninferior to 9 months of isoniazid (5 mg/kg/d), but RIF had higher rate of completion rates and better safety outcomes.  http://bit.ly/2AzY5O3
  2. Metanalysis of 266 studies examining 976,408 psoriasis patients shows the prevalence of PsA among patients with psoriasis was 19.7% (18.5%-20.9%). In children and adolescents (<18 years), the pooled prevalence was 3.3% https://t.co/RNo5yKbmvv
  3. Pfizers announces EU approval for tofacitinib 10 mg bid for use in adults with moderately to severely active ulcerative colitis (UC) who have had an inadequate response or intolerance to DMARD or biologic agents https://t.co/Cw9JFozphJ
  4. Olmstead county study of 429 gout patients shows that hospitalization was associated with a 10 fold increase risk of gout flares & in hosp gout flares prolonged hospitalization by avg of 1.8 days. (all highly significant) https://t.co/ICyq4RzCds 
  5. Study of >100,000 UK and Taiwan pts with incident gout shows gout confers significant risk of Joint replacement surgery (14-56% higher in gout) which was not reduced by urate lowering therapy. https://t.co/AnenjnJ4ks
  6. Positive Results from Phase III study of RHB-104 in Crohn’s Disease; RHB-104 is a combo antimycobacterial-antibiotic with antiinflammatory properties (given w/ hypothesis that CD caused by a mycobacterium avium paratuberculosis https://t.co/w78xCKkAlG
  7. Study of 6644 hip & femoral fractures found 2.95% were atypical femoral Fx (90 subtrochanter & 106 femoral shaft Fx). Risk factors were osteopenia/osteoporosis, RA, increased ant. & lat. femoral curvatures, & thicker lateral femoral cortex at the shaft https://t.co/vWsW0hLoHS
  8. Study of 72 AS and RA patients eligible to switch from etanercept originator to SB4 biosimilar shows that switch & good experience occurred in 85%, Those not switching were suspect of generics, older with longer disease duration https://t.co/iE0oFNHxbq   
  9. Opioid use remains high "US has the highest per capita rate of opioid use in the world...double that of 2nd Germany & 7X higher than the UK.... On average, 40 people die daily in the US from opioid overdoses, a four-fold increase since 1999 https://t.co/ejtX8er7k7
  10. Opioid Aversion is Augmenting Spinal Steroid Injections   NY TIMES  http://rheumnow.com/content/opioid-aversion-augmenting-spinal-steroid-in...  
  11. Maternal RA Increases Offspring Risk of Autoimmune Disorders  http://rheumnow.com/content/maternal-ra-increases-offspring-risk-autoimm...
  12. Statin Associated with an Increase in Inflammatory Myopathy  JAMA –IM  http://rheumnow.com/content/statin-associated-increase-inflammatory-myop...

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

U.S. News 2018-19 Rheumatology Rankings

The Annual U.S. News and World Report Rankings of Hospitals has listed the top contenders in the field of rheumatology. The U.S. News Review rates hospitals nationwide in 16 specialties – including rheumatology. Of the 4,500 hospitals covered by U.S. News that were analyzed, 158 were classified nationally in at least one specialty area.

The RheumNow Week in Review – No Good Gout (8.10.18)

Dr. Jack Cush reviews the news and latest journal articles from the past week on RheumNow.com. Info on Surgery and Hip Fractures, Gout drugs abandoned, Allopurinol escalation, hydroxychloroquine drug levels, how to treat scleroderma in India and exactly who gets back pain.

The RheumNow Week in Review – Lupus in the News (7.27.18)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

The RheumNow Week in Review – Cocoon Therapy? (7.20.18)

Dr. Jack Cush reviews highlights from the news and social media on RheumNow.com in the past week. 

Proposed Changes for 2019 Medicare Fee Schedule

On July 12th the Centers for Medicare & Medicaid Services (CMS) released its proposed rule changes for the 2019 Medicare physician fee schedule.  This year, CMS has combined the Medicare physician fee schedule proposed rule with recommendations for the Quality Payment Program (QPP), which will be officially published in the Federal Register on July 27.